Home  |  Contact
Due to maintenance work, this service will be unavailable Mon Feb 13 between 07:00 and 09:30 - CET. Apologies for the inconvenience.

Cellosaurus NRS-1 (CVCL_4871)

[Text version]

Cell line name NRS-1
Accession CVCL_4871
Resource Identification Initiative To cite this cell line use: NRS-1 (RRID:CVCL_4871)
Comments Population: Japanese.
Doubling time: 68 hours (at 15th passage), 64 hours (at 25th passage) (PubMed=7599791).
Sequence variations
  • Gene fusion; HGNC; 3819; FOXO1 + HGNC; 8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (PubMed=7599791).
Disease Alveolar rhabdomyosarcoma (NCIt: C3749)
Alveolar rhabdomyosarcoma (ORDO: Orphanet_99756)
Derived from metastatic site: Left calf muscle.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 7Y
Category Cancer cell line
STR profile Source(s): RCB

Markers:
AmelogeninX
CSF1PO12,13
D5S81811,12
D7S8208
D13S3178,11
D16S5399,10
TH019
TPOX9,11
vWA18,20

Run an STR similarity search on this cell line
Publications

PubMed=7599791; DOI=10.1007/BF00191348
Ogose A., Motoyama T., Hotta T., Watanabe H.
In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line.
Virchows Arch. 426:385-391(1995)

PubMed=23882450; DOI=10.3389/fonc.2013.00183
Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G., Linardic C.M.
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.
Front. Oncol. 3:183.1-183.12(2013)

PubMed=23665679; DOI=10.1038/onc.2013.129
Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.
Oncogene 33:1877-1889(2014)

Cross-references
Cell line collections RCB; RCB1188
Cell line databases/resources CLO; CLO_0050021
Biological sample resources BioSample; SAMN03472176
Encyclopedic resources Wikidata; Q54931041
Entry history
Entry creation04-Apr-2012
Last entry update20-May-2021
Version number15